LYMPHANGIOMA

Clinical trials for LYMPHANGIOMA explained in plain language.

Never miss a new study

Get alerted when new LYMPHANGIOMA trials appear

Sign up with your email to follow new studies for LYMPHANGIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1 Not yet recruiting 1

New hope for rare blood vessel tumors: everolimus trial launches

Disease control Not yet recruiting

This study tests the drug everolimus in 67 people with rare blood vessel growths (vascular anomalies) that haven't responded to other treatments. The goal is to see if everolimus can shrink these growths or improve symptoms. Participants take the drug daily for at least 6 months,…

Matched conditions: LYMPHANGIOMA

Phase: PHASE2 • Sponsor: Yonsei University • Aim: Disease control

Last updated May 17, 2026 10:27 UTC

LYMPHANGIOMA

Get alerted when new LYMPHANGIOMA trials appear

New hope for rare blood vessel tumors: everolimus trial launches